Involvement of Transient Receptor Potential Cation Channel Vanilloid 1 (TRPV1) in Myoblast Fusion

被引:11
|
作者
Kurosaka, Mitsutoshi [1 ]
Ogura, Yuji [1 ]
Funabashi, Toshiya [1 ]
Akema, Tatsuo [1 ]
机构
[1] St Marianna Univ, Dept Physiol, Sch Med, Kawasaki, Kanagawa, Japan
关键词
SKELETAL-MUSCLE HYPERTROPHY; SATELLITE CELLS; TRANSCRIPTION FACTORS; CAPSAICIN RECEPTOR; WEAK INDUCER; KAPPA-B; DIFFERENTIATION; PATHWAY; GROWTH; PROLIFERATION;
D O I
10.1002/jcp.25345
中图分类号
Q2 [细胞生物学];
学科分类号
071009 ; 090102 ;
摘要
The mechanisms that underlie the complex process of muscle regeneration after injury remain unknown. Transient receptor potential cation channel vanilloid 1 (TRPV1) is expressed in several cell types, including skeletal muscle, and is activated by high temperature and by certain molecules secreted during tissue inflammation. Severe inflammation and local temperature perturbations are induced during muscle regeneration, which suggests that TRPV1 might be activated and involved in the process. The aim of this study, was to clarify the role of TRPV1 in the myogenic potential of satellite cells responsible for muscle regeneration. We found that mRNA and protein levels of TRPV1 increased during regeneration after cardiotoxin (CTX)-induced muscle injury in mice. Using isolated mouse satellite cells (i.e., myoblasts), we observed that activation of TRPV1 by its agonist capsaicin (CAP) augmented myogenin protein levels. Whereas CAP did not alter myoblast proliferation, it facilitated myoblast fusion (evaluated using myonucleii number per myotube and fusion index). In contrast, suppression of TRPV1 by siRNA impaired myoblast fusion. Using mice, we also demonstrated that intramuscular injection of CAP facilitated muscle repair after CTX-induced muscle injury. Moreover, we showed that these roles of TRPV1 might be mediated by interleukin-4 and calcium signaling during myoblast fusion. Collectively, these results suggest that TRPV1 underlies normal myogenesis through promotion of myoblast fusion. J. Cell. Physiol. 231: 2275-2285, 2016. (c) 2016 Wiley Periodicals, Inc.
引用
收藏
页码:2275 / 2285
页数:11
相关论文
共 50 条
  • [21] Presynaptic inhibition of transient receptor potential vanilloid type 1 (TRPV1) receptors by noradrenaline in nociceptive neurons
    Chakraborty, Saikat
    Elvezio, Vincent
    Kaczocha, Martin
    Rebecchi, Mario
    Puopolo, Michelino
    JOURNAL OF PHYSIOLOGY-LONDON, 2017, 595 (08): : 2639 - 2660
  • [22] A journey from molecule to physiology and in silico tools for drug discovery targeting the transient receptor potential vanilloid type 1 (TRPV1) channel
    Amaya-Rodriguez, Cesar A.
    Carvajal-Zamorano, Karina
    Bustos, Daniel
    Alegria-Arcos, Melissa
    Castillo, Karen
    FRONTIERS IN PHARMACOLOGY, 2024, 14
  • [23] Functionally important amino acid residues in the transient receptor potential vanilloid 1 (TRPV1) ion channel - an overview of the current mutational data
    Winter, Zoltan
    Buhala, Andrea
    Oetvoes, Ferenc
    Josvay, Katalin
    Vizler, Csaba
    Dombi, Gyoergy
    Szakonyi, Gerda
    Olah, Zoltan
    MOLECULAR PAIN, 2013, 9
  • [24] Discovery of Novel 6,6-Heterocycles as Transient Receptor Potential Vanilloid (TRPV1) Antagonists
    Blum, Charles A.
    Caldwell, Timothy
    Zheng, Xiaozhang
    Bakthavatchalam, Rajagopal
    Capitosti, Scott
    Brielmann, Harry
    De Lombaert, Stephane
    Kershaw, Mark T.
    Matson, David
    Krause, James E.
    Cortright, Daniel
    Crandall, Marci
    Martin, William J.
    Murphy, Beth Ann
    Boyce, Susan
    Jones, A. Brian
    Mason, Glenn
    Rycroft, Wayne
    Perrett, Helen
    Conley, Rachael
    Burnaby-Davies, Nicola
    Chenard, Bertrand L.
    Hodgetts, Kevin J.
    JOURNAL OF MEDICINAL CHEMISTRY, 2010, 53 (08) : 3330 - 3348
  • [25] Blue Light Irradiation Induces Human Keratinocyte Cell Damage via Transient Receptor Potential Vanilloid 1 (TRPV1) Regulation
    Yoo, Ju Ah.
    Yu, Eunbi
    Park, See-Hyoung
    Oh, Sae Woong
    Kwon, Kitae
    Park, Se Jung
    Kim, Hyeyoun
    Yang, Seyoung
    Park, Jung Yoen
    Cho, Jae Youl
    Kim, Youn-Jung
    Lee, Jongsung
    OXIDATIVE MEDICINE AND CELLULAR LONGEVITY, 2020, 2020
  • [26] Increased Transient Receptor Potential Vanilloid Type 1 (TRPV1) Signaling in Idiopathic Overactive Bladder Urothelial Cells
    Li, Mingkai
    Sun, Yan
    Simard, J. Marc
    Chai, Toby C.
    NEUROUROLOGY AND URODYNAMICS, 2011, 30 (04) : 606 - 611
  • [27] The stress protein heat shock cognate 70 (Hsc70) inhibits the Transient Receptor Potential Vanilloid type 1 (TRPV1) channel
    Iftinca, Mircea
    Flynn, Robyn
    Basso, Lilian
    Melo, Helvira
    Aboushousha, Reem
    Taylor, Lauren
    Altier, Christophe
    MOLECULAR PAIN, 2016, 12
  • [28] Transient Receptor Potential Vanilloid-1 (TRPV1) Is a Mediator of Lung Toxicity for Coal Fly Ash Particulate Material
    Deering-Rice, Cassandra E.
    Johansen, Mark E.
    Roberts, Jessica K.
    Thomas, Karen C.
    Romero, Erin G.
    Lee, Jeewoo
    Yost, Garold S.
    Veranth, John M.
    Reilly, Christopher A.
    MOLECULAR PHARMACOLOGY, 2012, 81 (03) : 411 - 419
  • [29] Rat detrusor overactivity induced by chronic spinalization can be abolished by a transient receptor potential vanilloid 1 (TRPV1) antagonist
    Santos-Silva, Andre
    Charrua, Ana
    Cruza'b, Celia D.
    Gharat, Laxmikant
    Avelino, Antonio
    Cruz, Francisco
    AUTONOMIC NEUROSCIENCE-BASIC & CLINICAL, 2012, 166 (1-2): : 35 - 38
  • [30] Discovery of Novel 5,5-Diarylpentadienamides as Orally Available Transient Receptor Potential Vanilloid 1 (TRPV1) Antagonists
    Saku, Osamu
    Ishida, Hiroshi
    Atsumi, Eri
    Sugimoto, Yoshiyuki
    Kodaira, Hiroshi
    Kato, Yoshimitsu
    Shirakura, Shiro
    Nakasato, Yoshisuke
    JOURNAL OF MEDICINAL CHEMISTRY, 2012, 55 (07) : 3436 - 3451